Archives
Annexin V-Cy5 Apoptosis Kit in Microglia Research
2026-09-23
The Annexin V-Cy5 Apoptosis Kit provides a rapid way to assess phosphatidylserine exposure when studying cell-death responses alongside microglial lysosomal stress. Use it as a complementary readout—not a substitute for lysosomal-function assays—to test whether a stress phenotype involves apoptosis.
Cy5-UTP for RNA Probe Synthesis and Imaging
2026-09-23
Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, reducing dependence on post-synthesis staining. This guide connects practical RNA probe synthesis, FISH, and dual-color assay design with a cautious workflow for tracking labeled mRNA in lipid nanoparticle studies.
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-09-22
This study develops a hyaluronate-conjugated lipid nanoparticle that uses HA-DMG to combine particle stabilization, skin penetration, and CD44-directed uptake for topical PTEN mRNA delivery. In melanoma models, the platform restored PTEN expression, promoted immunogenic cell death, activated antitumor immunity, and suppressed tumor growth with limited observed toxicity.
Zosuquidar (LY335979): A Transporter-Aware MDR Guide
2026-09-22
Zosuquidar (LY335979) is examined here through a transporter-aware lens that connects P-gp inhibition with pharmacokinetic variability. Learn how disease-state biology, orthogonal assays, and careful controls can improve studies of multidrug resistance in cancer.
Targeted mRNA Nanoparticles in Ischemic Stroke
2026-09-21
Gao and colleagues developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to promote protective microglial polarization after ischemic stroke. In mouse models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, supporting targeted mRNA delivery as a potential poststroke intervention.
Microfluidic Peptide/RNA Complexes for Pulmonary Delivery
2026-09-21
Ma and colleagues developed cationic peptide/RNA complexes using microfluidic mixing and evaluated their stability during vibrating-mesh nebulisation. Both siRNA and mRNA formulations produced inhalable aerosols and retained RNA binding and in vitro transfection performance after aerosolisation, supporting further pulmonary delivery system research.
HyperScript™ IV RT SuperMix: RT-qPCR Guide
2026-09-20
HyperScript™ IV RT SuperMix for qPCR (with gDNA wiper) is a K1590 reverse-transcription quantitative PCR reagent for converting RNA into measurable cDNA signals. The referenced Magnaporthe oryzae study provides biological targets and benchmarks for expression analysis, but it does not establish product-specific performance.
Cy5-UTP: Reliable RNA Labeling for Cell Assays
2026-09-19
Learn how Cy5-UTP (Cyanine 5-UTP), SKU B8333, can add a defined RNA-level readout to cell viability, proliferation, and cytotoxicity workflows without being mistaken for a direct viability reagent. This scenario-based guide covers probe synthesis, fluorescence interpretation, storage, compatibility, and practical vendor selection.
EZ Cap™ Cas12a mRNA: Reading Editing Outcomes
2026-09-18
Discover how EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) can be evaluated as a transient Cas12a expression component by connecting PAM geometry, staggered cleavage, repair outcomes, and assay design. This article adds a mechanistic interpretation framework beyond routine workflow guidance.
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-18
Separate mRNA delivery from protein expression with one fluorescent reporter designed for mammalian-cell assays. This workflow shows how to use Cy5 tracking, EGFP translation, and modified nucleotides to compare delivery systems and troubleshoot inconsistent results.
Lyso-Tracker Red and Lysosomal Membrane Permeability
2026-09-17
Lyso-Tracker Red enables live-cell analysis of lysosomal acidification, morphology, and redistribution during treatment-induced cell death. This article explains how to use the probe more rigorously when investigating lysosomal membrane permeability, methuosis, apoptosis, and pyroptosis.
EZ Cap™ Cy5 EGFP mRNA for Macrophage Assays
2026-09-17
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates nanoparticle uptake from productive translation in macrophage gene-delivery studies. This evidence-based guide connects dual fluorescence with assay interpretation, formulation decisions, and translational relevance.
SPRTN Ubiquitin Binding and DPC Proteolysis
2026-09-16
The bioRxiv study identifies a ubiquitin-binding domain within the N-terminal catalytic region of SPRTN and shows that ubiquitin-chain recognition strongly stimulates proteolysis of DNA-protein crosslinks. Its central finding is that polyubiquitination is not merely a recruitment mark: it provides a specificity signal that increases SPRTN proteolytic activation by approximately 67-fold relative to unmodified crosslinks.
Ferritin Hybrid Vaccine for Influenza and SARS-CoV-2
2026-09-16
This study developed a ferritin-based hybrid protein particle that co-displays the influenza A M2e antigen and tandem SARS-CoV-2 S-protein epitopes. Production in Escherichia coli generated a multivalent particle with stronger antibody responses and functional antiviral activity than corresponding antigen-only or single-antigen ferritin constructs.
Ionizable and PEGylated Lipids in mRNA-LNP Potency
2026-09-15
This 2025 Journal of Controlled Release study shows that commonly used ionizable and PEGylated lipids can produce lipid nanoparticles with similar physical quality attributes but markedly different mRNA expression. Its combined HEK293-cell and mouse experiments demonstrate why particle size, dispersity, and encapsulation efficiency alone are insufficient predictors of in vivo potency.